Tezspire 210 MG/1.91 ML pen 1.91ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA0LZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,940
Award facts
- Contract value 100% obligated
- $4,939.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,939.58 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Tezspire 210 mg/1.91 mL pen injectors. The contract, which is not set-aside, has an ultimate completion date of December 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Tezspire is a biologic immunoglobulin E monoclonal antibody therapy used primarily for the treatment of moderate-to-severe eosinophilic asthma and chronic rhinosinusitis with nasal polyposis. AmerisourceBergen's extensive contract portfolio with the DLA demonstrates the company's critical role in supplying specialty pharmaceuticals and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other federal healthcare systems. The competitive award reflects the company's established capability to meet federal procurement requirements for specialized pharmaceutical products and maintain reliable supply chains for military medical needs.
Quick answers
Who was awarded contract SPE2DR26FA0LZ?
SPE2DR26FA0LZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DR26FA0LZ worth?
The government has obligated $4,940 on SPE2DR26FA0LZ.
Is contract SPE2DR26FA0LZ an order under another contract?
Yes. SPE2DR26FA0LZ is a delivery order under SPE2DR25D2100, an indefinite delivery contract.
Was contract SPE2DR26FA0LZ competed?
The extent of competition for SPE2DR26FA0LZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award